Xeriant Inc
OTC:XERI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Entheon Biomedical Corp
CNSX:ENBI
|
CA |
|
T
|
Twin Hospitality Group Inc
NASDAQ:TWNP
|
US |
Xeriant Inc
Research & Development
Xeriant Inc
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Xeriant Inc
OTC:XERI
|
Research & Development
-$113k
|
CAGR 3-Years
-17%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Boeing Co
NYSE:BA
|
Research & Development
-$3.6B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-1%
|
|
|
Howmet Aerospace Inc
NYSE:HWM
|
Research & Development
-$37m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
14%
|
|
|
Lockheed Martin Corp
NYSE:LMT
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Northrop Grumman Corp
NYSE:NOC
|
Research & Development
-$1.1B
|
CAGR 3-Years
3%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-4%
|
|
|
Raytheon Technologies Corp
NYSE:RTX
|
Research & Development
-$2.8B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-2%
|
|
Xeriant Inc
Glance View
Xeriant, Inc. is an aircraft design and development company. The company is headquartered in Boca Raton, Florida. The company went IPO on 2011-02-09. The firm is focused on acquiring, developing and commercializing technologies with applications in aerospace, including aircraft concepts targeting aviation industry.
See Also
What is Xeriant Inc's Research & Development?
Research & Development
-113k
USD
Based on the financial report for Dec 31, 2025, Xeriant Inc's Research & Development amounts to -113k USD.
What is Xeriant Inc's Research & Development growth rate?
Research & Development CAGR 3Y
-17%
Over the last year, the Research & Development growth was 21%. The average annual Research & Development growth rates for Xeriant Inc have been -17% over the past three years .
